Facilitated By

San Antonio Medical Foundation

News

  • Arvinas Announces Data Presentations from the Vepdegestrant (ARV - GuruFocus

    ... San Antonio Breast Cancer Symposium (SABCS), taking place December 9–12, 2025 in San Antonio, Texas. Vepdegestrant is a novel investigational ...

  • CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative ...

    Gonzalez Convention Center in San Antonio, Texas. Currently, mTNBC is associated with a poor prognosis. The efficacy of immune checkpoint inhibitors ( ...

  • Osisko Development (ODV) Sells San Antonio Gold Project to Axo Copper - GuruFocus

    ... San Antonio Gold Projec. ... Biotech Stocks Blockchain Stocks Chinese Stocks Dividend Stocks EV Stocks Growth Stocks Oil Stocks Value Stocks ...

  • CytoDyn to Present Leronlimab mTNBC Data at SABCS 2025 | CYDY Stock News

    ... San Antonio Breast Cancer Symposium (SABCS), being held December 9-12 ... Clearside Biomedical to Pursue Strategic Sale of its Business Through ...

  • REEP Earns Seventh Consecutive San Antonio Business Journal Fast Track Award

    Biotechnology · Clinical Trials & Medical Discoveries · Dentistry ... San Antonio Business Journal's Fast Track Awards for the seventh year in a row.